ArticleCancer immunology research2018

Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies.

Jing Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.